Data to Guide the “Test and Treat Era” of Hepatitis C
Authors:
- 1 October 2012
- journal article
- editorial
- Published by Elsevier in Gastroenterology
- Vol. 143 (4) , 887-889
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Predicted Effects of Treatment for HCV Infection Vary Among European CountriesGastroenterology, 2012
- The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007Annals of Internal Medicine, 2012
- Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrowLiver International, 2011
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2011
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis CClinical Gastroenterology and Hepatology, 2011
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus InfectionGastroenterology, 2011
- Boceprevir for Untreated Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2011
- Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆Digestive and Liver Disease, 2011
- Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus–Related CirrhosisClinical Gastroenterology and Hepatology, 2010
- The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwideJournal of Hepatology, 2006